EuropaBio, The European Association for bio-industries, and Smithers Rapra unveil highly-anticipated agenda for the European Forum for Industrial Biotechnology (EFIB) from 1-2 October 2013 taking place in the heart of Brussels at SQUARE. Officially launched by Elio di Rupo, Prime Minister of Belgium, EFIB’s opening plenary brings together a host of keynote speakers including Rudolf Strohmeier, Deputy Director General R&I at the European Commission; Maria da Graça Carvalho, Rapporteur on Horizon 2020 in the European Parliament and CEOs of Ecover and Galactic. Followed by exciting partnership perspectives from the Plant PET Technology Collaborative and a session lead by Ian Hudson, President of DuPont EMEA, examining the triggers for big business to make the shift towards the biobased economy. All speakers set the scene for another outstanding year, and transform the event from conference to congress.
The programme features parallel tracks, enabling delegates to build their agenda choosing from presentations on a range of recent developments. Delegates pick from the ever-popular innovation track, showcasing the brightest and best new innovations in IB from 2012-2013, or shorter in-depth focus tracks on sustainable and competitive feedstocks, international policy from the Americas and Asia, financing the bioeconomy, and a round table on BRIDGE – the proposed €3.8 billion Public Private Partnership on biobased industries.
Highlights of the sessions include Venture Capitalist, Jos Peeters, presenting an overview of financing for the biobased economy, perspectives on sustainable EU feedstock by Pekka Pesonen, Secretary General at Copa Cogeca, and insight into the current US biotechnology policy situation from Brent Erikson at BIO. Also this year, the innovation track showcases technological breakthroughs, new processes for innovative biobased products and innovative tools in the biobased economy from companies including Solvay, Direvo and BioAmber.
Seasoned journalist, editor and analyst of EU affairs, Jacki Davis, closes the plenary, with unmissable insight from Jack Huttner on the challenges of a biobased economy and the need for building a sustainable supply chain, followed by the EFIB business meets policy debate. Featuring visionary leaders from the industry including, Stephan Tanda, managing board member of DSM and Chair of EuropaBio, also SME Proviron and leading policymakers in the fields of innovation, biotechnology and the bioeconomy, including Maive Rute of DG Research and Innovation, examining whether the EU has what it takes to pull together to create a world leading biobased marketplace.
“We are delighted to host EFIB, in Brussels again this year, both during the first ever EU Biotech week and on the occasion of its transformation from conference to congress. EFIB has always been a crucible for forming new policy ideas and innovative business connections for biobased industries. This year will be no exception and we look forward to showcasing the brightest and the best developments of 2013 to a record number of participants”, says Nathalie Moll, Secretary General, EuropaBio. EFIB takes place 30 September – 2 October, SQUARE Brussels Meeting Centre, Belgium. View all the confirmed speakers